FVR, Etelä-Helsingin rokotetutkimusklinikka

The FVR, Etelä‑Helsingin rokotetutkimusklinikka conducts vaccine research aimed at preventing bacterial lung infections in children. Current studies examine pneumococcal immunisation to establish a comprehensive safety profile. Investigators are evaluating the tolerability of the novel PG4 vaccine across pediatric age groups.

• Safety assessment in healthy infants
• Immune response evaluation in children and adolescents
• Monitoring tolerability across age groups

The site operates as a non‑commercial health‑care institution in Helsinki, Finland, and currently supports two safety‑focused vaccine trials overseen by a single investigator.